Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes von Hippen, Keli L., Bucher, Christoph, Schirm, Dawn K., Bearl, Amanda M., Brender, Ty, Mink, Kathy A., Waggie, Kimberly S., Peffault de Latour, Regis, Janin, Anne, Curtsinger, Julie M., Dillon, Stacey R., Miller, Jeffrey S., Socie, Gerard, Blazar, Bruce R.

Volltext

Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia von Yun, Hyun Don, Schirm, Dawn K., Felices, Martin, Miller, Jeffrey S., Eckfeldt, Craig E.

Volltext

Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager von Felices, Martin, Lenvik, Todd R, Kodal, Behiye, Lenvik, Alexander J, Hinderlie, Peter, Bendzick, Laura E, Schirm, Dawn K, Kaminski, Michael F, McElmurry, Ron T, Geller, Melissa A, Eckfeldt, Craig E, Vallera, Daniel A, Miller, Jeffrey S

Volltext

Abstract 4939: Driving natural killer cell antigen-specific targeting of cancer via next generation trivalent molecules von Felices, Martin, Kodal, Behiye, Lenvik, Alexander J., Ettestad, Brianna, Bendzick, Laura, Ryan, Caitlin, Schirm, Dawn K., McElmurry, Ron, Eckfeldt, Craig E., Geller, Melissa A., Lenvik, Todd R., Vallera, Daniel A., Miller, Jeffrey S.

Volltext